INTRATUMOR MICROBIOME IN CANCER PROGRESSION: CURRENT DEVELOPMENTS, CHALLENGES AND FUTURE TRENDS


Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trial

Introduction Patients with a first venous thromboembolism (VTE) are at risk of recurrence.Recurrent VTE apac1/60/1/cw (rVTE) can be prevented by extended anticoagulant therapy, but this comes at the cost of an increased risk of bleeding.It is still uncertain whether patients with an intermediate recurrence risk or with a high recurrence and high bl

read more